Navigation Links
Topoisomerase in Medical News

CSHL scientists correlate enzyme expression levels with chemotherapy drug response

... or short-circuit this process." Regulating topoisomerase through gene "knockdown" The premise of the ... the expression of genes involved in producing topoisomerase enzymes. Four shRNAs were identified that ... Top2A, which codes for production of a particular topoisomerase ...

Sunesis Pharmaceuticals Presents Nonclinical Data on SNS-595 at the Annual Meeting of the American Association for Cancer Research

... as a site-selective DNA intercalator and topoisomerase poison with selectivity for proliferating cells. ... and may have advantages over other topoisomerase poisons," said Daniel C. Adelman, M.D., Senior ... in indications such as breast cancer where topoisomerase II poisons are active." Sunesis researchers ...

DNA with a twist: New company to search for cancer drugs and antibiotics

... enable drug-discovery work in this area including topoisomerase enzymes themselves as well as associated ... on the standard gel-based screening method for topoisomerase inhibitors. Inspiralis Ltd will develop the ... rapidly divide in an uncontrolled manner and topoisomerase inhibitors can block this uncontrolled cell ...

Sunesis Reports Financial Results for the First Quarter 2009

... clinical use for the treatment of breast cancer, including cisplatin and topoisomerase II inhibitors doxorubicin and etoposide. Data also established an enhanced ... for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, G2 ...

Sunesis Pharmaceuticals' SNS-595 Shows Clinical Activity in Patients With Relapsed or Refractory Acute Leukemias; Data Presented in Oral Session at 49th Annual Meeting of the American Society of Hematology

... a first-in-class naphthyridine analog that intercalates DNA and poisons topoisomerase II causing selective DNA damage, was administered on a weekly or twice ... a first-in-class naphthyridine analog that intercalates DNA and poisons topoisomerase II causing selective DNA damage, is currently in a Phase 1b clinical trial ...

Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia and Ovarian Cancer Will Be Presented at ASCO

... derivative, or AQD, a class of compounds that has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, G2 arrest and apoptosis. Voreloxin is currently being evaluated in a Phase 2 ...

Gene alterations associated with response to anthracycline therapy for breast cancer

... Alterations in the topoisomerase II alpha ( TOP2A ) gene were associated with better patient outcomes following anthracycline-based therapy compared with non-anthracycline-based ...

Biomarkers: What can they tell us

... M.D., Ph.D. Chemotherapy treatment selection based on biomarkers may not yet be a valuable practice. Prior studies have suggested that HER2 and topoisomerase II (TOP2A) might predict sensitivity to particular chemotherapy agents. An interim analysis shows that HER2 and TOP2A have a clinically modest and ...

Class of Chemotherapy Drugs Helps Certain Breast Cancer Patients

... should get anthracyclines based just on HER2 status. That's because other research has suggested that the overexpression of another gene called topoisomerase II alpha (or topo2) may also play a role in how well anthracyclines work. "The topo2 gene is thought to be the real target of the anthracyclines," ...

First look at an enzyme target for antibacterial and cancer drugs

... (Berkeley Lab) and the University of California (UC) at Berkeley have produced the first three-dimensional structural images of a DNA-bound Type II topoisomerase (topo II) that is responsible for untangling coiled strands of the chromosome during cell division. Preventing topo II from disentangling a cells ...
Topoisomerase in Medical Technology

Pixantrone in Combination with Chemotherapy Regimens Produces Overall Response Rates of 58-74% with Complete Remission Rates of 37-57% in Relapsed/Refractory Aggressive or Indolent NHL

... anthracyclines and the rational design modifications to the chemical compound believed to be responsible for enhanced DNA damage and binding to topoisomerase II enzyme, a key target for anthracycline mediated tumor death. These modifications are also hypothesized by the authors to underlie the drugs' low ...

Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology

... to quinolones, a class of compounds that has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, irreversible G2 arrest and apoptosis. Voreloxin is currently being evaluated in a ...

Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH

... to quinolones, a class of compounds that has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, irreversible G2 arrest and apoptosis. Voreloxin is currently being evaluated as a ...

Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium

... to quinolones, a class of compounds that has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site- selective DNA damage, irreversible G2 arrest and apoptosis. Voreloxin is currently being evaluated in a ...

Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association

... to quinolones, a class of compounds which has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, irreversible G2 arrest and rapid apoptosis. Voreloxin is currently being evaluated ...

Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)

... to quinolones, a class of compounds which has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication- dependent, site-selective DNA damage, irreversible G2 arrest and rapid apoptosis. Voreloxin is currently being ...

Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting

... to quinolones, a class of compounds which has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, irreversible G2 arrest and rapid apoptosis. In addition to the ongoing Phase 2 ...

Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress

... to quinolones, a class of compounds which has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, irreversible G2 arrest and rapid apoptosis. Voreloxin is currently being evaluated ...

Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia

... to quinolones, a class of compounds which has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site- selective DNA damage, irreversible G2 arrest and rapid apoptosis. The topoisomerase II-associated DNA ...

Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings

... an increase in SN38 exposure that was up to six-fold higher than the exposure previously reported with irinotecan at equivalent doses. SN38, a topoisomerase I inhibitor, is the active metabolite of irinotecan. The ASCO abstract reports interim data on 27 of 32 patients in the first of three dose ...
Topoisomerase in Medical Dictionary

Swelling

... excess fluid in body tissue s. edotecarin A substance that is being studied in the treatment of cancer . It belongs to the family of drugs called topoisomerase I inhibitors. Also called J-107088. Swelling of the eyelids and tissue s around the eyes , especially in the morning. Swelling of the ...

Toxins

... such as a specific food . A drug used to treat a variety of childhood cancer s. Epipodophyllo toxins belong to a larger class of drugs called topoisomerase II inhibitors. epirubicin ... Radiation Sunlight Tobacco Certain virus es Benzene Certain poison ous mushrooms and afla toxins (a poison ...
Topoisomerase in Biological News

New book, 'Untangling the Double Helix,' explores enzymes responsible for maintaining genome integrity

... general readership," wrote Wang. The book will appeal to those with a general interest in molecular biology, the biological and clinical aspects of topoisomerase function, or in the mathematics and physics of topology. Wang starts with the history of the "insuperable" DNA entanglement problem and describes ...

CTRC-AACR San Antonio Breast Cancer Symposium

... small HER2-positive tumors Evaluation of letrozole as adjuvant endocrine therapy Phase III trials of new, paradigm-shifting clinical agents like topoisomerase When: December 10-14, 2008 Where: Henry B. Gonzales Convention Center San Antonio, TX CTRC-AACR Press Room: Location: Room 217 ...

ESF EURYI award winner aims to stop cancer cells reading their own DNA

... much more specifically than traditional chemotherapy, avoiding side effects such as temporary hair loss. Dekker is focusing on an enzyme called topoisomerase IB that plays a key role in some of the molecular motors involved in the processes of DNA and RNA copying during cell division. These are responsible ...

Doing a spin with DNA

... featured on the cover of this issue. The enzyme topoisomerase IB releases the torsion built up in DNA strands. ... time as it acted on a single DNA molecule. The topoisomerase clamps onto the DNA, cuts through one of the two ... and under certain conditions even stop it. topoisomerase IB can reduce these torsional forces. The ...
Topoisomerase in Biological Technology

AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment

... Effects on Tubulin Polymerization and topoisomerase II", reviewed results of a pharmacological ... of action - inhibition of tubulin polymerization, topoisomerase activity as well as antiangiogenic properties - ... to the AEZS-112 profile is the inhibition of topoisomerase I by compounds 2 and 3. Moreover, compound 2 ...

AEterna Zentaris To Present Data on Anticancer Compounds AEZS-112 and AEZS-126 at AACR Annual Meeting

... compound, AEZS-126, as well as a poster on its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, at the American Association for Cancer ... outlines Phase 1 results for this orally-active tubulin and topoisomerase II inhibitor compound, in patients with advanced solid tumors and ...

Sunesis Reports Financial Results for the Second Quarter 2009

... derivative, or AQD, a class of compounds that has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, G2 arrest and apoptosis. Voreloxin is currently being evaluated in a Phase 2 ...

AEterna Zentaris Presents Phase 1 Results for AEZS-112 in Patients with Advanced Cancer and Lymphoma at AACR Annual Meeting in Denver

... company focused on endocrine therapy and oncology, today presented a poster outlining Phase 1 results for its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the ...

Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results

... derivative, or AQD, a class of compounds that has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, G2 arrest and apoptosis. Voreloxin is currently being evaluated in a Phase 2 ...

Sunesis Pharmaceuticals Provides Year-End Clinical Update on Voreloxin

... to quinolones, a class of compounds that has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, irreversible G2 arrest and apoptosis. Voreloxin is currently being evaluated in a ...

Positive SPA Reply From the FDA for TopoTarget's Pivotal Trial With Belinostat in PTCL

... the molecular mechanisms of cancer. Focus lies on highly predictive cancer models and key cancer targets (including HDACi, NAD+, mTOR, FasLigand and topoisomerase II inhibitors). TopoTarget has a broad cllinical pipeline with 9 products in development, including belinostat which has shown proof of concept ...

Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today

... a treatment in a broad number of cancers; - SN2310 is a novel prodrug of SN-38, which is a potent anti-cancer drug belonging to the class of topoisomerase I inhibitors. SN2310 is designed to enhance the delivery and exposure of SN-38 to the tumor by providing greater prodrug conversion and a ...

Poniard Pharmaceuticals Appoints Four New Members to Clinical Advisory Board

... on developing investigational agents and evaluating these compounds in Phase 1 and 2 clinical trials. He has published papers on taxanes and topoisomerase I inhibitors. He currently serves on the American Society of Clinical Oncology (ASCO) Board of Directors and is a member of ASCO's Ethics ...

Sonus Pharmaceuticals and OncoGenex Technologies to Merge

... a treatment in a broad number of cancers; - SN2310 is a novel prodrug of SN-38, which is a potent anti-cancer drug belonging to the class of topoisomerase I inhibitors. It is currently in a Phase 1 trial and progress is being made to determine its safety and pharmacokinetic profile, in ...
Topoisomerase in Biological Products

Human Topoisomerase II, Alpha from USB Corp.

Description:... Source: E. coli containing a clone of the human topoisomerase II gene. Description: topoisomerase II alters the topological state of nucleic acids ... catenate/decatenate or knot/unknot DNA molecules. topoisomerase II has an absolute requirement for divalent ...
Company:USB Corp.

Human Topoisomerase II, Alpha from USB Corp.

Description:... Source: E. coli containing a clone of the human topoisomerase II gene. Description: topoisomerase II alters the topological state of nucleic acids ... catenate/decatenate or knot/unknot DNA molecules. topoisomerase II has an absolute requirement for divalent ...
Company:USB Corp.

Vaccinia DNA Topoisomerase I from EPICENTRE Biotechnologies

Description:... topoisomerase I from vaccinia virus is a type I eukaryotic topoisomerase that removes both positive and negative ... positive or negative superhelical turns. DNA topoisomerase I does not absolutely require Mg 2+ to function, ...
Company:EPICENTRE Biotechnologies

Vaccinia DNA Topoisomerase I from EPICENTRE Biotechnologies

Description:... topoisomerase I from vaccinia virus is a type I eukaryotic topoisomerase that removes both positive and negative ... positive or negative superhelical turns. DNA topoisomerase I does not absolutely require Mg 2+ to function, ...
Company:EPICENTRE Biotechnologies

Calf Topoisomerase I from USB Corp.

Description:... Source: Calf thymus Description: topoisomerase I relaxes both positively and negatively ... bonds (1,2) . Relaxing supercoiled DNA with topoisomerase I allows molecules to be differentiated by a single nucleotide pair by gel electrophoresis (3) . topoisomerase I is active in the absence of Mn 2+ and can be ...
Company:USB Corp.

Human Topoisomerase I Wild Type from Calbiochem

Description:... µM EDTA, 20% glycerol, pH 7.9. AVOID FREEZE/THAW CYCLES. Human DNA topoisomerase I (Topo I) is a monomeric protein of 765 amino acids encoded by a ... energy. In addition to DNA replication and transcriptional activation, DNA topoisomerase I also plays a major role in pre-mRNA splicing, cell cycle and other gene ...
Company:Calbiochem

HTP Zero Blunt TOPO PCR Cloning Kit for Sequencing MultiShot E. coli from Invitrogen

Description:... most effective technology available for cloning PCR products. TOPO TA Cloning and Zero Blunt TOPO vectors are supplied linearized and activated with topoisomerase I. This enables 5-minute, bench-top ligation and yields >=95% ...
Company:Invitrogen

HTP Zero Blunt TOPO PCR Cloning Kit for Sequencing MultiShot StripWell E. coli from Invitrogen

Description:... most effective technology available for cloning PCR products. TOPO TA Cloning and Zero Blunt TOPO vectors are supplied linearized and activated with topoisomerase I. This enables 5-minute, bench-top ligation and yields >=95% ...
Company:Invitrogen

Zero Blunt TOPO PCR Cloning Kit with One Shot Mach1 T1 Phage-Resistant Chemically Competent E. coli from Invitrogen

Description:... high-efficiency (>=95%) cloning of blunt-end PCR products amplified with proofreading thermostable polymerases. The kit includes the linearized and topoisomerase I-activated pCR-Blunt II-TOPO vector for 5-minute bench-top ligations without ligase (1). The pCR-Blunt II-TOPO vector also ...
Company:Invitrogen

Zero Blunt TOPO Kit for Sequencing with One Shot Mach1 T1 Phage-Resistant Chemically Competent E. coli from Invitrogen

Description:... vector provides blunt ends for cloning PCR products amplified with proofreading thermostable polymerases. Each vector is supplied linearized and topoisomerase I-activated enabling 5-minute bench-top ligation yielding recombinants (1). Both vectors ...
Company:Invitrogen

More>>

Topoisomerase in Biological Dictionary

Topoisomerase

... topoisomerase I solves the problem caused by tension generated by winding/unwinding of DNA. ... See also topoisomerase inhibitor ... Eukaryotic type II topoisomerase cannot introduce supercoils; it ... In cancers, ...

Gyrase

... a second type IIA topoisomerase, ... Type I topoisomerase - Type II topoisomerase ( gyrase , topoisomerase IV) ... gyrase One of the type II ...

DNA gyrase

... a unique combination of a classical type I DNA topoisomerase ... DNA gyrase is distinct from all other ... DNA gyrase . ... DNA gyrase is a type II topoisomerase responsible for the manipulation of the ... ... supercoiling and re ... trapping of gyrase and topoisomerase IV on DNA probably ... gyrase removes ...

Ribonucleotides

... Ribonucleotides located within the 4 bp cleavage stagger stimulate topoisomerase ... The positional effect of ribonucleotides on topoisomerase II-mediated cleavage ... Ribonucleotides are difficult to activate ...

Recombinase

... Cre recombinase , often abbreviated to Cre, is a Type I topoisomerase from P1 bacteriophage that catalyzes site-specific recombination of ... DNA inversion in the Salmonella ... Cre Recombinase is a Type I topoisomerase from bacteriophage P1 that catalyzes ... Is the Cre Recombinase ...

Relaxed DNA

... If a DNA ... ... twisting it about the other strand, to relax DNA to a thermodynamic equilibrium. Once DNA is relaxed , topoisomerase reconnects broken strands. Structure ... ... with the amount of relaxed DNA to get you going and ... Relaxed , modified pBR-322 1000 ug ...

Endoreduplication

... the level of endoreduplication in epidermal cells ... Key words: Endoreduplication , gradient of gibberellic acid, lipid bodies, ... DNA topoisomerase VI Is Essential for Endoreduplication in Arabidopsis ... Endoreduplication is a common process in eukaryotes that involves DNA ... ... E ...

More>>

Other Contents
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
(Date:4/15/2014)... New research published in the March/April 2014 issue ... Nutrition shows whey protein, either as a supplement ... weight-loss or weight-maintenance diet, may provide men and women ... included 14 randomized controlled trials with a total of ... studies that used whey protein to replace calories in ...
(Date:4/14/2014)... the Puerto Rican climate over the past three decades ... frog, the territory,s national animal. UCLA biologists have found ... their mating call has also become shorter and higher ... distinguished professor of integrative biology and physiology and of ... physics researcher, the study examined 170 male coqui frogs ...
(Date:4/14/2014)... chamber bound for the International Space Station inside ... may help expand in-orbit food production capabilities in ... they don,t take for granted, fresh food. , ... the in-orbit function and performance of a new ... plant "pillows." The investigation will focus on the ...
Breaking Biology News(10 mins):New meta-analysis builds on the power of whey protein for improved body composition 2New meta-analysis builds on the power of whey protein for improved body composition 3Climate change a likely culprit in coqui frog's altered calls, say UCLA biologists 2Veggie will expand fresh food production on space station 2
Other TagsOther Tags